Viewing Study NCT05677334


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-02-20 @ 10:10 PM
Study NCT ID: NCT05677334
Status: COMPLETED
Last Update Posted: 2025-03-12
First Post: 2022-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
Sponsor: First Affiliated Hospital of Guangxi Medical University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2022-K148-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators